+35.3%
CLSK vs IVZ
+134.4%
-99.1%
-75.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | IVZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.0% | -1.0% | +2.0% | +2.0% |
| 7D | -10.1% | +0.8% | -11.0% | -11.0% |
| 30D | -26.6% | +2.0% | -28.6% | -28.0% |
| 3M | -47.1% | -10.8% | -36.2% | -40.1% |
| 6M | -53.8% | +6.1% | -59.9% | -56.5% |
| YTD | -38.6% | +12.4% | -51.0% | -45.9% |
| 1Y | -42.6% | +30.3% | -72.8% | -56.6% |
| All | +35.3% | +134.4% | -99.1% | -48.7% |
Cumulative growth
Daily Returns
Daily percentage return beside IVZ.
Daily Out/Under-Performance
Portfolio return minus IVZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IVZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded IVZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling